Tesamorelin vs Sermorelin: How Two GHRH Peptides Compare in 2026

Tesamorelin and sermorelin are both GHRH analogues, meaning they signal your pituitary to release your own growth hormone rather than replacing it. The main differences are structure and history. Sermorelin is a shorter GHRH fragment with a brief half-life that closely mimics natural GH pulses. Tesamorelin is a longer, chemically stabilized molecule studied specifically for reducing visceral fat in HIV-associated lipodystrophy, which is its FDA-approved use. pru offers sermorelin today through licensed physicians and 503A pharmacies.

Tesamorelin vs sermorelin: what's the real difference?

Tesamorelin and sermorelin are both GHRH analogues, so both work by prompting the pituitary to release growth hormone (GH) rather than injecting GH directly. The practical split comes down to three things: molecule size, how long each lasts in the body, and the research behind each.

Sermorelin is a 29-amino-acid fragment of natural GHRH with a very short half-life, so it produces GH in brief pulses that resemble the body's own rhythm. Tesamorelin is a larger 44-amino-acid molecule with a chemical modification that helps it last longer and drive higher GH and IGF-1 peaks.

History is the other big difference. Sermorelin once held FDA approval (as Geref) and is now prescribed as a compounded peptide. Tesamorelin is FDA-approved today, but only for one narrow use: reducing excess belly fat in adults with HIV-associated lipodystrophy. For a broader look at this family, see the growth hormone peptides guide.

What is a GHRH analogue, and why does it matter here?

A GHRH analogue is a peptide built to mimic growth hormone-releasing hormone, the natural signal your hypothalamus sends to your pituitary gland. Instead of adding growth hormone from outside, a GHRH analogue asks your own pituitary to make and release it. Both tesamorelin and sermorelin fall into this class, which is why people compare them so often. The appeal, at least in theory, is a more natural pattern of GH release than injecting synthetic GH, since the pituitary still governs the timing.

Because both peptides act on the same GHRH receptors, the differences you feel or measure come from dose, molecule design, and half-life rather than a totally different mechanism. That is the frame to keep in mind as we compare them.

Tesamorelin vs sermorelin at a glance

Here is the side-by-side. Sermorelin and tesamorelin share a mechanism but differ sharply in structure, duration, regulatory status, and the research each carries. Use this table as the fast reference, then read the sections below for context on each row.

What is tesamorelin, and what is it studied for?

Tesamorelin is a synthetic 44-amino-acid GHRH analogue. Its defining feature is a trans-3-hexenoic acid group attached to the molecule, which helps it resist an enzyme (DPP-4) that would otherwise break it down quickly. That gives it a longer half-life than sermorelin and lets it drive higher, more sustained GH and IGF-1 levels.

Tesamorelin is the only GHRH analogue with a specific FDA approval: reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. In pooled Phase III trials of 806 participants, it reduced visceral adipose tissue by about 15% versus placebo over 26 weeks. In 2025 the FDA approved a newer formulation, marketed as EGRIFTA WR, that moves patients from daily to weekly reconstitution. Outside that HIV indication, tesamorelin use is off-label and less studied, and it is not currently part of pru's catalog.

What is sermorelin, and why is it the more common choice?

Sermorelin is a 29-amino-acid peptide that represents the active fragment of natural GHRH (often written GHRH 1-29). Because it is short-acting, it produces growth hormone in brief pulses that resemble the body's own release pattern, then clears quickly. That pulse-like profile is a big part of why clinicians reach for it.

Sermorelin also has a distinct regulatory history: it was previously FDA-approved as Geref for pediatric growth hormone deficiency, then voluntarily discontinued in 2008 and withdrawn in 2009 for commercial, not safety, reasons. Today it is prescribed as a compounded peptide through 503A pharmacies. That prior-approval background is one reason sermorelin is the more widely used GH peptide, and it is the one pru offers. Learn more in the sermorelin guide or compare it with a common pairing in sermorelin vs ipamorelin.

Which one is right for you, tesamorelin or sermorelin?

Neither peptide is universally 'better'; they suit different goals, and only a licensed physician can confirm fit. Sermorelin tends to suit people looking for gentle, pulse-like GH support with a long prescribing history behind it. Tesamorelin's strongest evidence is narrow and specific, tied to visceral fat in HIV-associated lipodystrophy, so its case outside that setting is thinner.

• Leaning sermorelin: you want a short-acting, pulse-like GHRH peptide with a prior-approval history and current availability.
• Curious about tesamorelin: your interest is visceral fat, but note its evidence base is centered on an HIV-related condition and it is not yet in pru's catalog.
• Either way: a physician reviews your health history, and you choose the peptide with pru's guidance rather than a doctor picking for you.

If your goal is body composition or training recovery more broadly, it is worth reading best peptides for muscle growth and peptides for athletic performance before deciding.

What are the safety considerations for these peptides?

Both peptides raise growth hormone and, downstream, IGF-1, so the safety themes overlap. For tesamorelin, reported effects can include injection-site reactions, joint or muscle aches, swelling (edema), and elevated IGF-1, which is why clinicians monitor IGF-1 during use. Tesamorelin is not used in people with active cancer, and its long-term cardiovascular and cancer-risk profile is not fully established. Sermorelin shares the general GHRH-analogue cautions and can cause injection-site reactions.

None of this is medical advice, and none of these peptides should be used without a prescriber. A physician screens for conditions like active malignancy, reviews your labs, and decides whether a GH peptide is appropriate for you at all. See sermorelin side effects for a fuller rundown on that peptide specifically.

Why does the source of these peptides matter so much?

The single biggest safety variable is where the peptide comes from. Online sellers market 'research-grade' tesamorelin and sermorelin vials labeled 'not for human use,' with no prescriber, no pharmacy oversight, and no verified potency or sterility. That grey-market supply is where the real risk sits: you cannot confirm what is in the vial, how it was made, or whether it is contaminated.

This is why pru routes everything through licensed prescribers and 503A pharmacies rather than shipping unverified vials. For the wider 2026 regulatory picture, including the FDA's PCAC review of peptides, see the growth hormone peptides guide.

How does pru handle these GHRH peptides?

pru offers sermorelin today as a pharmacy-grade compounded peptide. A licensed physician reviews your intake and confirms whether it fits your health history; you select the peptide, guided by pru's content, and the doctor confirms fit rather than choosing for you. An FDA-regulated 503A pharmacy compounds and fills the prescription. You can see it on the sermorelin product page or browse the Muscle & Performance catalog.

Pricing is transparent and at-cost. A flat membership of about $50 a month, billed annually, funds the platform; the peptide itself is billed separately at cost, meaning pharmacy fill, supplies, shipping, the consult, and a small platform fee, with no markup on the medicine. As the dose rises the medicine can cost a little more, but it never carries a member markup. See pricing for the full breakdown.

Tesamorelin is not in pru's catalog yet. It is a planned addition, pending the FDA's PCAC review of the broader peptide landscape. Until then, sermorelin is pru's live GHRH peptide. Looking into GHRH peptides at all is a proactive step, and being proactive here means choosing the provider that makes the informed path the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing in one place. When you are ready to take that next step, sermorelin is here through pru.

Related reading

• Sermorelin guide: how it works and who it's for
• Sermorelin vs ipamorelin: comparing GH peptides
• Growth hormone peptides guide
• Best peptides for muscle growth
• Where to buy sermorelin safely
• Shop sermorelin at pru

Common questions